Global Experts Meeting on

Neurological Disorders and Stroke

Melbourne, Australia   November 16-17, 2017

stroke meeting-2017

Melbourne, Australia November 16-17, 2017


On behalf of Meeting International, We announce Global Experts Meeting on Neurological Disorders and Stroke which will be held on  November 16-17, 2017 at Melbourne, Australia.

The conference will be organized around the theme” Latest Developments in Understanding Neurological Disorders”. We will likely convey a remarkable program which covers the whole range of research in neurological issue and share the culturally diverse encounters of different treatment methodology.

Stroke 2017 is an annual meeting of Neuroscience organizations as well as Neurological Disorders committees to discuss the future of the Neurological disorders in terms of collaboration, structures and organizational development.

Meetings International provides a Global Platform for Pharma Biotech, Medical and Healthcare Professionals to Exchange Ideas, Knowledge and Networking at its 100+ International Conferences.

Global Experts Meeting On Neurological disorders and Stroke is a one of a kind gathering to unite overall recognized scholastics in the field of neuroscience and neurology, Brain analysts, general wellbeing experts, researchers, scholastic researchers, industry specialists, researchers to trade about best in class research and innovations.

Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of Stroke-2017.

On behalf of the committee, we welcome you to join the upcoming 3rd International Conference on Neurological Disorders and Stroke during November 16-17, 2017 at Melbourne, Australia.

Track 1: Neurological Disorders

A neurological issue is any turmoil of the sensory system. Basic, biochemical or electrical irregularities in the mind, spinal line or different nerves can bring about a scope of manifestations. Cases of manifestations incorporate loss of motion, muscle shortcoming, poor coordination, and loss of sensation, seizures, perplexity, torment and adjusted levels of cognizance. There are more than 600 neurologic infections. Some of the time they can come about because of biochemical causes also. The pervasiveness rates of the range of neurological issue from various locales of the nation extended from 967-4,070 with a mean of 2394 for each 100000 populaces, giving an unpleasant gauge of more than 30 million individuals with neurological issue (barring neuroinfections and traumatic wounds). Commonness and rate rates of normal issue including epilepsy, stroke, Parkinson's ailment and tremors decided through populace based studies indicate extensive variety crosswise over various districts of the nation. The requirement for an institutionalized screening poll, uniform philosophy for case ascertainment and determination is a fundamental essential for creating strong national information on neurological issue. Higher rates of pervasiveness of neurological issue in provincial ranges, 6-8 million individuals with epilepsy and high case casualty rates of stroke (27-42%) call for pressing procedures to set up effort neurology administrations to take into account remote and country regions, create National Epilepsy Control Program and set up stroke units at various levels of social insurance pyramid.

Track 2: Neuro Degeneration

Neurons are the building pieces of the sensory system which incorporates the cerebrum and spinal string. Neurons typically don't imitate or supplant themselves, so when they get to be distinctly harmed or bite the dust they can't be supplanted by the body. Neurodegeneration is the umbrella term for the dynamic loss of structure or capacity of neurons, including demise of neurons. Numerous neurodegenerative ailments including amyotrophic parallel sclerosis, Parkinson's, Alzheimer's, and Huntington's happen as an aftereffect of neurodegenerative procedures. Dementias are in charge of the best weight of sickness with Alzheimer's speaking to around 60-70% of cases.

Track 3: Cerebrovascular disorders

The word cerebrovascular is comprised of two sections – "cerebro" which alludes to the substantial part of the mind, and "vascular" which implies supply routes and veins. Together, the word cerebrovascular alludes to blood stream in your cerebrum. The term cerebrovascular illness incorporates all issue in which a territory of the mind is briefly or for all time influenced by ischemia or draining and at least one of the cerebral veins are included in the neurotic procedure. Cerebrovascular illness incorporates stroke, carotid stenosis, vertebral stenosis and intracranial stenosis, aneurysms, and vascular mutations. Confinements in blood stream may happen from vessel narrowing (stenosis), clump arrangement (thrombosis), blockage (embolism), or vein break (discharge). Absence of adequate blood stream (ischemia) influences mind tissue and may bring about a stroke. There were an expected 157,803 cerebrovascular-related passings in 2003; 138,397 of which were in individual’s age 65 and more seasoned.

Track 4: Spine & Spinal Disorders

This Session will incorporate The Neurospinal Disorders finding and therapeutics for patients experiencing all sicknesses of the spine and fringe nerves. For exact analyses and expanded security amid restorative methodology, pros utilize the most exceptional procedures accessible for spinal imaging, interventional neuroradiology, electro-physiological testing, and surgery.

Track 5: Stroke and its Management

A stroke is a restorative crisis. Strokes happen when blood stream to your mind stops. Inside minutes, cerebrum cells start to kick the bucket. There are two sorts of stroke. The more normal kind, called ischemic stroke, is created by a blood coagulation that squares or attachments a vein in the cerebrum. The other kind, called haemorrhagic stroke, is brought on by a vein that breaks and seeps into the cerebrum. "Smaller than normal strokes" or transient ischemic assaults (TIAs), happen when the blood supply to the cerebrum is quickly interfered. Stroke is the third driving reason for death in the United States. Of the more than 700,000 individuals influenced each year, around 500,000 of these are first assaults, and 200,000 are intermittent. Around 25 percent of individuals who recuperate from their first stroke will have another stroke inside five years. Stroke is a main source of genuine long haul handicap, with an expected 5.4 million stroke survivors presently alive today. The American Heart Association assesses that in 2003, stroke cost about $51.2 billion in both immediate and circuitous expenses in the United States alone.

Track 6: Brain Tumors & Neuro Oncology

Essential cerebrum tumors can be either harmful (contain growth cells) or considerate (don't contain disease cells). An essential mind tumor is a tumor which starts in the cerebrum. In the event that a destructive tumor which begins somewhere else in the body sends cells which wind up developing in the cerebrum, such tumors are then called optional or metastatic mind tumors. This talk is centered around essential cerebrum tumors. Mind tumors can happen at any age. The correct reason for cerebrum tumors is not clear. The manifestations of cerebrum tumors rely on upon their size, sort, and area. The most widely recognized side effects of mind tumors incorporate cerebral pains; deadness or shivering in the arms or legs; seizures, memory issues; state of mind and identity changes; adjust and strolling issues; sickness and regurgitating; changes in discourse, vision, or hearing.

Track 7: Multiple sclerosis

Multiple sclerosis (MS) influences the cerebrum and spinal string. Early MS manifestations incorporate shortcoming, shivering, deadness, and obscured vision. Different signs are muscle solidness, thinking issues, and urinary issues. Treatment can calm MS side effects and postpone ailment movement. The reason for MS is thought to be exchange of hereditary and natural components, including scope as well as presentation to daylight and vitamin D levels. Impacts the age when side effects begin

Track 8: Neuropsychiatry and Mental health

Neuropsychiatry is a branch of medicine that deals with mental disorders attributable to diseases of the nervous system. It preceded the current disciplines of psychiatry and neurology. Neurologists have focused objectively on organic nervous system pathology, especially of the brain, whereas psychiatrists have laid claim to illnesses of the mind. Major Neuropsychiatric Conditions include the following: Addictions, Childhood and development, Eating disorders, Degenerative diseases, Mood disorders, Neurotic disorders, Psychosis & Sleep disorders.

Track 9: Neuropsychology & Behavioural Sciences

The study of the relationship between behaviour, emotion, and cognition on the one hand, and brain function on the other. Neuropsychology studies the structure and function of the brain as they relate to specific psychological processes and behaviors. Clinical Neuropsychology is a specialty in professional psychology that applies principles of assessment and intervention based upon the scientific study of human behavior as it relates to normal and abnormal functioning of the central nervous system. The specialty is dedicated to enhancing the understanding of brain‐behavior relationships and the application of such knowledge to human problems.

Track 10: Neuropharmacology

Neuropharmacology discusses the drug-induced changes in functioning of the nervous system. The specific focus of this course will be to provide a description of the cellular and molecular actions of drugs on synaptic transmission. Refer to specific diseases of the nervous system and their treatment in addition to giving an overview of the techniques used for the study of neuropharmacology.

Track 11: Neuro Diagnosis & Imaging techniques

Diagnostic tests and procedures are vital tools that help physicians confirm or rule out the presence of a neurological disorder or other medical condition. Development of techniques that allow scientists to see inside the living brain and monitor nervous system activity as it occurs. Researchers and physicians use a variety of diagnostic imaging techniques and chemical and metabolic analyses to detect, manage, and treat neurological disease.  Some procedures are performed in specialized settings, conducted to determine the presence of a particular disorder or abnormality.  Many tests that were previously conducted in a hospital are now performed in a physician’s office or at an outpatient testing facility, with little if any risk to the patient.  Depending on the type of procedure, results are either immediate or may take several hours to process.

Track 12: Neurology and Nursing

Neurology is the enclosure of medical research and practices that devoirs disorders and issues of the nervous system, including the brain. Doctors specialized in diagnosing patients and their problems whereas neurology nurses are one who trained to aid these doctors in the treatment of patients with neurological issues. Neurology nurse deals with giving both post-operative care and immediate care. Various conditions Like Parkinson’s disease, brain tumours, encephalitis, multiple sclerosis and meningitis, as well as those who have suffered from trauma, such as stroke victims and those who have had spinal or brain.

Track 13: Neurosurgery

Neurosurgery, or neurological surgery, is the restorative claim to fame worried with the counteractive action, determination, surgical treatment, and recovery of clutters which influence any segment of the sensory system including the mind, spinal string, fringe nerves, and additional cranial cerebrovascular framework. The fundamental headways in neurosurgery came to fruition as an aftereffect of profoundly created apparatuses. Advanced neurosurgical devices, or instruments, incorporate etches, curettes, dissectors, distractors, lifts, forcepts, snares, impactors, tests, suction tubes, control devices, and robots.

Track 14: Neurological disorders: Research and Treatments

Following diagnosis, treatment options, including medications (topical, oral, and intravenous), device-based therapies (such as deep brain stimulation), surgeries (such as procedures to remove tumours), physical therapy, and rehabilitation. Major requirements include clinical skill, cutting-edge research, and personalized attention to provide comprehensive care for a range of neuropsychological disorders and conditions.

Track 15: Therapeutics Approaches for Neurological Disorders

Apart from the issue of a cure, sometimes patients with neurological issues can be placed in rehabilitation as part of an effort to restore some lost function. This is usually a hopeful sign, as it’s rare to find a patient assigned to therapy when there’s little to no hope of at least a partial recovery. Therapies for neurological disorders may often consist of: Lifestyle changes to either prevent or minimize the impact of such conditions, Physiotherapy to manage the symptoms and restore some function; Pain management, as much impairment can be associated with considerable discomfort; Medication to either restore function or prevent a worsening of the patient’s condition.

Track 16: Clinical Trails & Case Reports

With a regularly expanding normal future, Neurological and Stroke Disorders are turning out to be more common in the public arena. The monetary and social expenses of Neurological and Stroke Disorders to society are immense. Numerous enormous pharmaceutical organizations have moved far from CNS and Neurology look into. This meeting will give designates a chance to increase extra profound experiences into the accepted procedures in clinical trials, and also tending to the difficulties in Stroke and Neurology inquire about and by taking a gander at the most recent preclinical and clinical studies.


Theme:  Latest Developments in Understanding Neurological Disorders

About the Conference:

Stroke Meetings 2017 welcomes academic, presenter, industrialist and exhibitors from all over the world to Melbourne, Australia. We are glad to invite you all to attend and register for the “Global Experts Meeting on Neurological Disorders and Stroke” which is going to be held during November 16-17, 2017 in Melbourne, Australia. A broad audience gathering for exploring the advancement in neurological disorders and stroke which focusses on prevention and treatment of neurological disorders and stroke.

The organizing committee is gearing up for an exciting and informative conference program on a variety of topics, poster presentations and various programs for participants from all over the world. Stroke Meetings 2017 will be a platform where you will be sure to have a meaningful experience with scholars from around the world. All members of the Stroke Meeting 2017 -organizing committee look forward to meeting you in Melbourne, Australia.

For more details please visit-

 Importance and Scope:

Global Experts Meeting on Neurological Disorders and Stroke is an annual meeting of Neuroscience organizations as well as Stroke committees to discuss the future of the Neurological disorders in terms of collaboration, structures and organizational development. Brain researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies. Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of Stroke Meeting 2017. Conferences, National symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about Stroke Meeting 2017 and its allied areas.

Why Melbourne???

In 2010, mental, neurological and substance use disorders accounted for 10.4% of global DALYs, 2.3% of global YLLs and, 28.5% of global YLDs, making them the leading cause of YLDs. Mental disorders accounted for the largest proportion of DALYs (56.7%), followed by neurological disorders (28.6%) and substance use disorders (14.7%). DALYs peaked in early adulthood for mental and substance use disorders but were more consistent across age for neurological disorders. Females accounted for more DALYs in all mental and neurological disorders, except for mental disorders occurring in childhood, schizophrenia, substance use disorders, Parkinson's disease and epilepsy where males accounted for more DALYs. Overall DALYs were highest in Eastern Europe/Central Asia and lowest in East Asia/the Pacific.

Institutions, transport, business, communication, events and conference hub bridging healthcare professionals from the seven continents annually to collaborate and exchange knowledge and research.

Disorders of the nervous system and senses organs were the third major cause of disease burden in WA in 2006. It is predicted that in 2016, disorders of the nervous system and senses organs will continue to be third major cause of disease burden.  Dementia was the first leading cause of disease burden in WA for females and the second for males in 2006. In 2006, disorders of the nervous system and senses organs were the second leading cause of disability burden in WA. In WA in 2006, the leading causes of disability due to nervous system and senses organ disorder for females were dementia (44.2%), adult onset hearing loss (10.2%) and migraine (8.4%). For males the leading causes of disability were dementia (27.1%), adult-onset hearing loss (29.8%) and Parkinson’s disease (7.3%). For WA, nervous system diseases hospitalisations accounted for 2.4 % of all hospitalisations by principal diagnosis between 2008 and 2012.  Between 2001 and 2012, the rate of nervous system disease hospitalisations increased significantly. The age group most affected by nervous system diseases is 45-64 year olds. In 2012, there were 31,804 occasions of hospital admission for conditions due to nervous system diseases. These admissions totalled 340,627 bed-days at an approximate cost of $307,114,587. The percentage of Aboriginal people who were hospitalised for the following causes were; epilepsy (22%) cerebral palsy (13%), hydrocephalus (7%), spina bifada (11.5%) and traumatic brain injury (10%). In 2013, 18 953 patients attended 30 608 appointments at public neurology non-admitted outpatient clinics in WA. Between 2004-2014, there were 111 433 ED attendances across WA with a primary diagnosis of a neurological condition. The conditions with the highest frequency of ED attendance for specific neurological diagnosis were acquired brain injury (25%), epilepsy (24%), migraine (18%), transient ischaemic attacks (14%) and stroke (6%). In WA, nervous system diseases accounted for 8.8% of all deaths between 2007 and 2011.The average number of deaths due to nervous system diseases in WA between 2007 and 2011 was 1107 per year. It is estimated that there are over 19 800 people who are currently members of WA based community neurological organisations and/or receive services and supports from these agencies. Services provided may be of a clinical or non-clinical nature.

Conference Highlights:

·         Central Nervous System Disorders

·         Cerebrovascular disorders and stroke

·         Neurological and degenerative disorders

·         Neurological disorders and Chronic Pain

·         Neurological disorders and surgery

·         Stroke and its Management

·         Neuro Oncology

·         Stroke Rehabilitation and Recovery

·         Pediatrics: Neurological disorders and stroke

·         Therapeutic Approaches for Neurological Disorders and Stroke

·         Brain Tumour and Imaging

·         Neuro Pharmacology

·         Clinical Trails & Case Reports

·         Stroke Rehabilitation and Recovery

·         Therapeutic Approaches for stroke

Why to attend???

3rd International Conference on Neurological Disorders and Stroke is a unique forum to bring together worldwide distinguished academics in the field of neuroscience and neurology, Brain researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies.

Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of Stroke 2017.

A Unique Opportunity for Advertisers and Sponsors at this International event


Target Audience

·         Directors,

·         Head of Department

·         Professors 

·         Industrial

·         Neurologist

·         Neuroscientist

·         Neuro-oncologist

·         Neuroradiologist

·         Neurosurgeons

·         Psychiatrist

·         Students from Academia in the research of neurology


Member Associated with Neurological disorders and Stroke research in World

·         American Association of Neurological Surgeons

·         American Stroke Association

·         American Academy of Neurology

·         European Neurological Societies

·         World Federation of Neurology

·         Spanish Society of Neurology

·         National Stroke Association

Member Associated with Neurological disorders and Stroke research in Australia

Australian Association of Neurologists

Australian Neuroscience Society

Australian Association of Neurologists

Neurosurgical Society of Australia

Member Associated with Neurological disorders and Stroke research in Melbourne

·         Society for Neuroscience  Melbourne

·         Australasian Society for Social and Affective Neuroscience      

Universities associated with Neurological disorders and Stroke research in World

·        Stanford University

·         University of California

·        University of South Carolina Beauport

·         University of Helsinki

·         California Institute of Technology

·         Yale University

·         Harvard University 

·         University of Pennsylvania

·         University of Chicago

·         The Kavli Institute for Brain Science

·         Cornell University

·         Johns Hopkins University

·         North-western University

·         Hacettepe University, Institute of Oncology, Turkey

·         Sydney Medical School

·         Institute for Stroke and Dementia Research, Munich

·         Brain Research Institute, UCLA

Top Hospitals Associated with Neurological Disorders and Stroke Research in World     

·         Cleveland Clinic         

·         St Jude Children's Research Hospital

·         Johns Hopkins Medicine        

·         Mayo Clinic Scottsdale AZ     

·         University of Maryland Medical Center        

·         Massachusetts General Hospital       

·         Memorial Sloan Kettering Cancer Center     

·         New York Presbyterian / Lower Manhattan Hospital           

·         Providence Health & Services           

·         Deer's Head Hospital Center 

·         Buddhist Tzu Chi General Hospital    

·         Beth Israel Deaconess Medical Center Needham    

·         Taipei Veterans General Hospital     

·         American Hospital, Dubai

Societies Associated with Neurological and Stroke in World

·         American Society of Neurorehabilitation, USA

·         Stroke Society of Australasia – AUSTRALIA

·         Belgian Stroke Council - BELGIUM

·         Brazilian Stroke Network - BRAZIL

·         Canadian Stroke Consortium - CANADA

·         The Chinese Stroke Association (CSA) - CHINA

·         The Japan Stroke Society - JAPAN

·         Korean Stroke Society - KOREA, SOUTH

·         Romanian National Stroke Association - ROMANIA

·         European Stroke Organization - SWITZERLAND

·         Taiwan Stroke Society - TAIWAN

·         Ukrainian Society for Neurorehabilitation - UKRAINE

·         British Association of Stroke Physicians (BASP) - UNITED KINGDOM


 Companies Associated With Neurological Disorders and Stroke in World

Abbott Laboratories

Cordis Corporation

Boston Scientific Corporation

Siemens AG

Genentech, Inc.

Koninklijke Philips N.V.

Medtronic plc

GE Healthcare

Stryker Corporation

Merck & Co., Inc


Impax labs




Forest Laboratories

Chelsea therapeutics

Upshers-smith laboratories

Companies Associated With Neurological Disorders and Stroke in UAE

·         Pfizer UAE      

·         Johnson & Johnson Middle East         

·         Novo Nordisk Pharma Gulf

·         Gulf Pharmaceutical Industry-Julphar (JULPHAR)     

·         Smart Health and Nutrition Ltd.

·         Hikma Pharmaceuticals PLC  

·         Valeant Pharmaceuticals MEA FZ LLC

·         Sanofi Aventis UAE     

·         Astra Zeneca UAE      

·         BioPharma

·         Gulf Inject


Companies Associated With Neurological Disorders and Stroke in Dubai

·         AbbVie Biopharmaceuticals GmbH, Dubai

·         Merck Serono Middle East, Dubai

·         Hospira, Dubai

·         AstraZeneca, Dubai

·         Al-Hayat Pharmaceuticals     

·         Amgen

·         Elis Pharmaceuticals Limited


Market Value of Neurological disorders and Stroke research

The Global neurology market contributes to $34.5 billion which includes major countries such as US (74%), Europe (64%), japan (8.3%), and UAE (7.8%).


Fund Allotment to Neurological disorders and Stroke Research

NINDS- National Institute of Neurological Disorders and Stroke Funding Strategy- $1.6bi

NIHR- National Institute for Health Research- $1.05 bi

GAIS- Global Acute Ischemic Stroke- $3.6 bi

HBP- Human Brain Project - $ 1.3bi

BRI- Brain Research Initiative -$ 0.1 bi

AR- Alzheimer’s Research UAE -$ 0.009 bi



·         The Human Brain Project- The main goal of the HBP is to deliver a collaboratively built first draft "scaffold" model and simulation of the human brain by 2023.

·         Healthy People 2020- It is a statement of national health objectives designed to identify the most significant preventable threats to health and to establish national goals to reduce these stroke threats.

·         NeuroSeeker - It is a wide scale integrated project launched January 1st, 2013 partly funded for 4 years by the 7th Framework Programme of the European Commission under the Future Emerging Technologies initiative.

·         Neurologists / neuroscientist- Demand for neurologists are projected to increase from ∼18,180 to 21,440 by 2025.

·         Global Burden of Disease: A collaborative Project (2005 to 2030)

WHO launched a number of global public health projects, including the Public Health and Global Initiative on Neurology and whose purpose is to increase professional and public awareness of the occurrence, extent and costs of disorders and to emphasize the need to provide neurological care at all levels including primary health care.

·         SITS-WATCH project

SITS-WATCH project aims to reduce the delay between arriving at hospital and initiation of thrombolysis from 65 minutes reduced to 40 minutes aiming treatment benefits to at least half of all patients. This project is global within SITS and will cover all 65 member countries.

·         American Stroke Association

The American Heart Association/American Stroke Association developed methodology to project the future costs of stroke-related care.  By 2030, 3.88% of the US population (>18 years of age) is projected to have or had a stroke. Between 2012 and 2030, total direct annual stroke-related medical costs are expected to increase by 61% i.e. $184.13 billion.

·         Human Connectome

The NIH Human Connectome Project is an ambitious effort to map the neural pathways that underlie human brain function. The objective of Project is to acquire and share data about the structural and functional connectivity of the human brain.

·         The MindScope project

The project was started at the Allen Institute for Brain Science is part of our ambitious, ten-year plan to embark on meaningful understanding of how the brain works.

  • Stroke
  • Cerebrovascular disorders
  • Spine & Spinal Disorders
  • Stroke and its Management
  • Brain Tumors & Neuro Oncology
  • Multiple sclerosis
  • Neuropsychiatry and Mental health
  • Neuropsychology & Behavioural Sciences
  • Neuropharmacology
  • Neuro Radiology & Imaging techniques
  • Neurology and Nursing
  • Neurosurgery
  • Neurological disorders: Research and Treatments
  • Therapeutic Approaches for Neurological Disorders
  • Clinical Trails & Case Reports